Immunotherapy with Transfer Factor

Publisher Website
Google Scholar
Abstract
IT is one of life's little ironies that certain investigative findings are destined to appear initially somewhat exotic or obscure only to have the principle resurface after a variable eclipse and provide lucid insights into the cause of disease or a potent means of restoring health. This has been the recent fate of transfer factor in its successful application to the immunotherapy of a variety of infectious and immunodeficiency diseases.1 , 2 The report by Bullock, Fields and Brandriss on leprosy elsewhere in this issue of the Journal provides an example of this principle. Their carefully controlled evaluation of the potential use . . .